Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?

After more than a decade of preclinical and clinical development, therapeutic infusion of mesenchymal stromal cells is now a leading investigational strategy for the treatment of acute graft-versus-host disease (GVHD). While their clinical use continues to expand, it is still unknown which of their...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunavin, Neil, Dias, Ajoy, Li, Meizhang, McGuirk, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618297/
https://www.ncbi.nlm.nih.gov/pubmed/28671556
http://dx.doi.org/10.3390/biomedicines5030039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618297/
https://www.ncbi.nlm.nih.gov/pubmed/28671556
http://dx.doi.org/10.3390/biomedicines5030039

Ejemplares similares